Tiotropium/olodaterol in COPD: Disadvantages in some patients, advantages in others
(Institute for Quality and Efficiency in Health Care) For most patients, the fixed-dose combination has neither advantages nor disadvantages. More flare-ups occur in higher severity grades. Women with rare flare-ups have advantages.
Source: EurekAlert! - Medicine and Health - Category: Global & Universal Source Type: news
More News: Chronic Obstructive Pulmonary | Health | Health Management | International Medicine & Public Health | Spiriva | Tiotropium | Women